← Leaderboards
Thomas E. Carey
University Of Michigan At Ann Arbor
$14,226,111
Attributed
$16,064,602
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2006–21$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$16,064,602 · 9
By mechanism
R01$11,286,974 · 5
U01$3,676,983 · 1
P50$1,100,439 · 2
M01$206 · 1
Top collaborators
- John Chadwick Brenner4 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Maureen Agnes Sartor$7,415,011
- Carol R. Bradford$953,310
- John Chadwick Brenner$5,304,456
- John V Moran$18,547,664
- Qiao Li$286,781
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionResponseTumorResistanceMolecularMalignant Mouth NeoplasmDesignDiagnosisRecurrenceCharacteristicsSiteMalignant NeoplasmsHead And Neck CancerNeoplasm MetastasisAffectIn VitroPublic Health RelevanceBaseMorbidity - Disease RateHuman SubjectClinical ResearchProgramsGenesInterest
Grant awards (45)
Molecular Mechanisms of Tumor Behavior and Response to Therapy in HPV-positive Oropharyngeal Cancer$80,805
R01 · FY2021 · CA · contact PI
Molecular Mechanisms of Tumor Behavior and Response to Therapy in HPV-positive Oropharyngeal Cancer$500,865
R01 · FY2020 · CA · contact PI
Molecular Mechanisms of Tumor Behavior and Response to Therapy in HPV-positive Oropharyngeal Cancer$52,669
R01 · FY2020 · CA · contact PI
Molecular Mechanisms of Tumor Behavior and Response to Therapy in HPV-positive Oropharyngeal Cancer$454,350
R01 · FY2019 · CA · contact PI
Molecular Mechanisms of Tumor Behavior and Response to Therapy in HPV-positive Oropharyngeal Cancer$111,977
R01 · FY2019 · CA · contact PI
Dissecting Co-Dependent Pathways in Oral Cancers$925,806
U01 · FY2018 · DE
Molecular Mechanisms of Tumor Behavior and Response to Therapy in HPV-positive Oropharyngeal Cancer$483,596
R01 · FY2018 · CA · contact PI
Molecular Mechanisms of Tumor Behavior and Response to Therapy in HPV-positive Oropharyngeal Cancer$67,341
R01 · FY2018 · CA · contact PI
Dissecting Co-Dependent Pathways in Oral Cancers$925,806
U01 · FY2017 · DE
Molecular Mechanisms of Tumor Behavior and Response to Therapy in HPV-positive Oropharyngeal Cancer$498,336
R01 · FY2017 · CA · contact PI
Dissecting Co-Dependent Pathways in Oral Cancers$919,237
U01 · FY2016 · DE · contact PI
Molecular Mechanisms of Tumor Behavior and Response to Therapy in HPV-positive Oropharyngeal Cancer$512,654
R01 · FY2016 · CA · contact PI
Dissecting Co-Dependent Pathways in Oral Cancers$906,134
U01 · FY2015 · DE · contact PI
Defining Antigenic Targets of Autoimmune Sensorineural Hearing Loss$452,969
R01 · FY2014 · DC · contact PI
Defining Antigenic Targets of Autoimmune Sensorineural Hearing Loss$432,468
R01 · FY2013 · DC · contact PI
Defining Antigenic Targets of Autoimmune Sensorineural Hearing Loss$452,969
R01 · FY2012 · DC · contact PI
Biomarkers to Guide Treatment and Improve Survival in Oral/Oropharyngeal Cancer$340,706
R01 · FY2012 · DE · contact PI
C3: Tissue and Histopathology$232,813
P50 · FY2012 · CA · contact PI
Defining Antigenic Targets of Autoimmune Sensorineural Hearing Loss$452,969
R01 · FY2011 · DC · contact PI
Biomarkers to Guide Treatment and Improve Survival in Oral/Oropharyngeal Cancer$333,825
R01 · FY2011 · DE · contact PI
C3: Tissue and Histopathology$220,026
P50 · FY2011 · CA · contact PI
Defining Antigenic Targets of Autoimmune Sensorineural Hearing Loss$480,284
R01 · FY2010 · DC · contact PI
Biomarkers to Guide Treatment and Improve Survival in Oral/Oropharyngeal Cancer$344,149
R01 · FY2010 · DE · contact PI
C3: Tissue and Histopathology$249,043
P50 · FY2010 · CA · contact PI
Biomarkers to Guide Treatment and Improve Survival in Oral/Oropharyngeal Cancer$347,625
R01 · FY2009 · DE · contact PI
C3: Tissue and Histopathology$249,126
P50 · FY2009 · CA · contact PI
Defining Antigenic Targets of Autoimmune Sensorineural Hearing Loss$420,556
R01 · FY2008 · DC · contact PI
C3: Tissue and Histopathology$149,431
P50 · FY2008 · CA · contact PI
Defining Antigenic Targets of Autoimmune Sensorineural Hearing Loss$432,301
R01 · FY2007 · DC · contact PI
Defining Antigenic Targets of Autoimmune Sensorineural Hearing Loss$422,052
R01 · FY2006 · DC · contact PI
PREDICTING RESPONSE TO THERAPY: DETECTION OF ORAL CANCER$391,443
R01 · FY2003 · DE
ANTIGENIC TARGETS AUTOIMMUNE SENSORINEURAL HEARING LOSS$292,640
R01 · FY2003 · DC
PREDICTING RESPONSE TO THERAPY: DETECTION OF ORAL CANCER$391,091
R01 · FY2002 · DE
CHROMOSOME 18 TUMOR SUPPRESSOR GENES IN ORAL CANCER$317,707
R01 · FY2002 · DE
ANTIGENIC TARGETS AUTOIMMUNE SENSORINEURAL HEARING LOSS$285,989
R01 · FY2002 · DC
PREDICTING RESPONSE TO THERAPY: DETECTION OF ORAL CANCER$4,137
R01 · FY2002 · DE
GALANIN /GALANIN RECEPTORS--MARKERS OF TUMOR PROGRESSION$0
P50 · FY2002 · CA
PREDICTING RESPONSE TO THERAPY: DETECTION OF ORAL CANCER$376,661
R01 · FY2001 · DE
CHROMOSOME 18 TUMOR SUPPRESSOR GENES IN ORAL CANCER$308,450
R01 · FY2001 · DE
ANTIGENIC TARGETS AUTOIMMUNE SENSORINEURAL HEARING LOSS$272,484
R01 · FY2001 · DC
PREDICTING RESPONSE TO THERAPY: DETECTION OF ORAL CANCER$366,559
R01 · FY2000 · DE
CHROMOSOME 18 TUMOR SUPPRESSOR GENES IN ORAL CANCER$299,467
R01 · FY2000 · DE
ANTIGENIC TARGETS AUTOIMMUNE SENSORINEURAL HEARING LOSS$270,695
R01 · FY2000 · DC
PREDICTING RESPONSE TO THERAPY: DETECTION OF ORAL CANCER$34,185
R01 · FY2000 · DE
GENE EXPRESSION IN AUDITORY HAIR CELLS$206
M01 · FY2000 · RR